AM
Alistair Milnes
Chief Operating Officer

Alistair Milnes insider trades: Bicycle Therapeutics (BCYC) stock sales

Chief Operating Officer, Bicycle Therapeutics Last trade Jan 5, 2026 19 Form 4 filings
$44K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Alistair reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 5, 2026BCYC↓ Sell$44K
Oct 3, 2025BCYC↓ Sell$18K
Jul 3, 2025BCYC↓ Sell$15K
Apr 3, 2025BCYC↓ Sell$17K
Jan 3, 2025BCYC↓ Sell$78K
Oct 3, 2024BCYC↓ Sell$22K
Jul 3, 2024BCYC↓ Sell$19K
Apr 3, 2024BCYC↓ Sell$23K
Jan 3, 2024BCYC↓ Sell$46K
Oct 3, 2023BCYC↓ Sell$9K
Jul 3, 2023BCYC↓ Sell$11K
Apr 3, 2023BCYC↓ Sell$9K
Jan 3, 2023BCYC↓ Sell$52K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BCYC insiders

Open-market trades in the last 12 months

About Alistair Milnes's insider trades

Alistair Milnes is Chief Operating Officer at Bicycle Therapeutics (BCYC). Since Jan 3, 2023, Alistair has reported no open-market purchases and 13 sales worth $364K on SEC Form 4. In the last 12 months: 1 sale ($44K).

Their filings also include grants and awards (9 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCYC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.